Beyond the switch to the biosimilar of natalizumab: What is the impact of changing the JCV test?, PMID:40515642
Association between rapid and sustained remission and clinician- and patient-reported outcomes in patients with rheumatoid arthritis: post hoc analysis of data from the SELECT-COMPARE study., PMID:40514717
Clinical and prognostic profiles in immune-mediated hypertrophic meningitis: a retrospective analysis of 92 cases., PMID:40504382
French guidelines for the diagnostic and management of MOG antibody-associated disease., PMID:40494723
Anti-VGLUT2 autoantibodies in neurological diseases., PMID:40494504
Novel pretransplant desensitization strategies in heart transplantation., PMID:40486117
Triple positivity for autoantibodies in patients with rheumatoid arthritis is associated with a severe course of the disease but not with bone turnover markers., PMID:40485950
Cluster analysis identifies three clinical patterns of patients with systemic autoimmune diseases and anti-Ku antibodies., PMID:40473271
Belatacept in Kidney Transplantation: Reflecting on the Past, Shaping the Future., PMID:40463417
EXPRESS: Risk Factors Associated with Adenocarcinoma Development in Gastric Neuroendocrine Tumors: A Multicenter 10-year Follow-up Study., PMID:40459006
Avelumab plus sacituzumab govitecan versus avelumab monotherapy as first-line maintenance treatment in patients with advanced urothelial carcinoma: JAVELIN Bladder Medley interim analysis., PMID:40456670
Amyloidosis-Related Cardiomyopathy Revealing Waldenstrom Macroglobulinemia: A Case Report., PMID:40453263
Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial., PMID:40450141
Combination of encorafenib and binimetinib followed by ipilimumab and nivolumab versus ipilimumab and nivolumab in patients with advanced melanoma with BRAFV600E or BRAFV600K mutations (EBIN): an international, open-label, randomised, controlled, phase 2 study., PMID:40449497
A novel monoclonal antibody differentiates highly pathogenic serotype 4 fowl adenovirus through targeting 188R in the Hexon., PMID:40446681
Lichenoid graft-versus-host disease shows a high interferon score, with IFNAR1 inhibition preventing skin inflammation., PMID:40439472
MPO-ANCA-Associated Hypertrophic Pachymeningitis Mimicking IgG4-Related Disease: A Case Report and Literature Review., PMID:40438183
PET imaging of TREM2 in amyloid-beta induced neuroinflammation., PMID:40434494
Developing and Characterizing the Tumor-Targeting Efficiency of an Anti-EphA2-CD11b Bispecific Antibody., PMID:40434019
Immunogenic Properties of a Novel Hepatitis A Vaccine Candidate Based on a Fast-Growing Viral Strain., PMID:40432058
Cognitive Impairment in ANCA-Associated Vasculitis: A Cross-Sectional Pilot Study., PMID:40429578
Impact of 10% vs. 5% immunoglobulin products on treatment outcomes in Kawasaki disease: a multicenter retrospective study., PMID:40425706
Multiplex base editing to protect from CD33 directed drugs for immune and gene therapy., PMID:40425554
Characteristics of SARS-CoV-2-associated severe episodes of monoclonal gammopathy-associated capillary leak syndrome (Clarkson disease)., PMID:40419837
Navigating the introduction of anti-amyloid therapy in Europe: a position statement by individual members of the EADC., PMID:40413561
Myositis specific autoantibody subtypes are associated with response to Janus kinase inhibitors in patients with juvenile dermatomyositis., PMID:40411753
Preclinical ImmunoPET Imaging of Thyroid-Stimulating Hormone Receptor Expression in Thyroid Cancer using [64Cu]Cu-NOTA-TSHR-Ab., PMID:40403201
Critical insights for intensivists on Guillain-Barré syndrome., PMID:40394364
IL-1β Signaling modulates T follicular helper and regulatory cells in human lymphoid tissues., PMID:40392614
Importance of early detection and treatment of occupational hypersensitivity pneumonitis., PMID:40392119
Interplay between sarcopenia, GDF-15, and the efficacy of nivolumab plus ipilimumab in patients with mismatch repair deficient metastatic colorectal cancer: final survival analysis of the phase II GERCOR NIPICOL study., PMID:40389373
Anti-PD-1 antibody enhances homeostatic proliferation-induced antitumor immunity during lymphopenia recovery., PMID:40386771
180-day efficacy of nirsevimab against hospitalisation for respiratory syncytial virus lower respiratory tract infections in infants (HARMONIE): a randomised, controlled, phase 3b trial., PMID:40379431
Tryptophan-kynurenine metabolites associate with inflammation and immunologic phenotypes in common variable immunodeficiency., PMID:40378971
Effects of Janus kinase inhibitors in adults admitted to hospital due to COVID-19: a systematic review and individual participant data meta-analysis of randomised clinical trials., PMID:40378861
Progressive repigmentation of hypopigmented lesions in discoid lupus erythematosus with anifrolumab: A report of two cases., PMID:40378274
Targeting interferon responses in juvenile dermatomyositis: Siglec-1 as an in vitro biomarker for JAK inhibitor efficacy., PMID:40372702
Relapsed/refractory multiple myeloma: standard of care management of patients in the Gulf region., PMID:40352314
Patient-reported outcomes from DESTINY-Breast04: trastuzumab deruxtecan versus physician's choice of chemotherapy in patients with HER2-low mBC., PMID:40349139
Site-specific quantification of the in vivo UFMylome reveals myosin modification in ALS., PMID:40347946
Molecular diagnosis of kidney allograft rejection based on the Banff Human Organ Transplant gene panel: a multicenter international study., PMID:40345499
Increased delay to lung transplantation for women candidates: gender-based disparity matters in the lung transplant trajectory., PMID:40337341
Structural basis for hepatitis E virus neutralization by potent human antibodies., PMID:40333967
DOMENICA: dostarlimab versus chemotherapy alone in first-line MMR-deficient advanced endometrial cancer patients., PMID:40323277
Role of Glycoprotein 3 in neutralizing antibody recognition of porcine reproductive and respiratory syndrome virus., PMID:40319969
Phase II trial of atezolizumab (Anti-PD-L1) in the treatment of relapsed/refractory IIB/IVB mycosis fungoides/Sézary syndrome patients after previous systemic treatment. EORTC-1652-CLTG "PARCT"., PMID:40319676
The mRNA vaccine expressing fused structural protein of PRRSV protects piglets against PRRSV challenge., PMID:40318244
The commercial PRRSV attenuated vaccine can be a potentially effective live trivalent vaccine vector., PMID:40316839
A phase I, open-label, multicentre, first-in-human study to evaluate safety, pharmacokinetics and efficacy of AMG 404, a PD-1 inhibitor, in patients with advanced solid tumours., PMID:40316348
[Seronegativity and anti-CD20: When a treatment compromises the diagnosis]., PMID:40312237
For research use only. Not for human or drug use.
